Regimbeau's insights

Exploring the present to provide you with the keys to the future

As a leading IP law firm, Regimbeau has always considered knowledge sharing to be the logical corollary of its excellent IP expertise.

Our experts regularly write for major international IP journals and contribute to Regimbeau’s reputation.

All
Undo all
Undo all
Undo all
0 100
Réinitialiser
Publications - 28 May 2020

G3/19: Products exclusively obtained by an essentially biological method finally excluded from patentability

By Philippe BESSIERE
Publications - 11 May 2020

EPO extends possibility of oral proceedings by videoconference to opposition proceedings

Publications - 21 Apr 2020

Implementation of the E.U. "Trademark reform package" in France: the French TM Office now competent to invalidate or revoke Trademark registrations

By Carole ADJADJ
Publications - 20 Apr 2020

IP management in times of crisis: what priorities? REGIMBEAU by your side during this critical period of COVID 19

By Katia Pouilly Stéphanie Massin Célaire and Isabelle Mary
Publications - 24 Mar 2020

Personal Data and "Covid-19 Alert"

By Aleksandra THÉLOT
Publications - 23 Mar 2020

Unified Patent Court - the German federal Constitutional court has finally issued its decision regarding the ratification process in Germany

By Sylvain Thivillier and Henri BOURGEOIS
Publications - 09 Mar 2020

PACTE Law: Opposition to patents

By Stéphanie Massin Célaire and Henri BOURGEOIS
Publications - 04 Feb 2020

PACTE law: changes relating to examination of French patent applications

By Henri BOURGEOIS
Publications - 02 Feb 2020

BREXIT but no panic! You will have still time to make a decision!

By Evelyne Roux
Publications - 29 Jan 2020

PACTE LAW: changes relating to Utility Certificates and establishment of a provisional patent application

By Stéphanie Massin Célaire
Publications - 28 Jan 2020

The NEURIM approach may be restricted or even dismissed. Once again, an advocate general recommends a reversal of jurisprudence. What will the Court's position ultimately be?

Publications - 28 Jan 2020

CRISPR/CAS9 failed to edit EPO priority entitlement case law

By Nicolas Bouquin, Ph.D and Lucile Vernoux, Ph.D
Regimbeau Institute

Find out more about our next formations and webinars

Take part in the futur meetings

Apply
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.